Other substances

Corilagin

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Supporting references

Link	Tested on	Impact factor	Notes	Publication date
Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay Preprint Screening	in vitro		inhibitor of the ACE2-RBD interaction	Jun/16/2020

AI-suggested references

Link	Publication date
Corilagin and 1,3,6-Tri-O-galloy-beta-D-glucose: potential inhibitors of SARS-CoV-2 variants.	Jun/07/2021
Plant-Derived Natural Non-Nucleoside Analog Inhibitors (NNAIs) against RNA-Dependent RNA Polymerase Complex (nsp7/nsp8/nsp12) of SARS-CoV-2.	Dec/01/2021
Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding.	May/05/2021
In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in Ayurveda medicine in inhibiting SARS-CoV-2.	Jan/11/2021
Plant-Derived Antiviral Compounds as Potential Entry Inhibitors against Spike Protein of SARS-CoV-2 Wild-Type and Delta Variant: An Integrative in SilicoApproach	Oct/04/2021
Molecular Interactions of Tannic Acid with Proteins Associated with SARS-CoV-2 Infectivity	May/11/2022
Corilagin inhibits SARS-CoV-2 replication by targeting viral RNA-dependent RNA polymerase.	Feb/15/2021
Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay.	Mar/29/2021
Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations	Dec/31/2021
In-Silico Identification of Natural Compounds from Traditional Medicine as Potential Drug Leads against SARS-CoV-2 Through Virtual Screening	Nov/09/2021
Targeting ACE2-RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay.	Nov/17/2020
Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins	Nov/11/2020